Replies to post #4759 on Echo Therapeutics Inc fka ECTE

[ramad]

New funding at these prices will bring extreme dilution. If the raise is $3M at
60 cents an additional 5M shares will be added. To reduce the the dilution MTIA might negotiate an adjustment in their royalty agreement or possibly scratch the Clinical trials with the old CGM and focus on the new CGM. That would delay the clinical trials with results until the latter part of the 1st quarter of 2017 and would not see revenue until the 3rd quarter of 2017. If you recall MTIA was not going to commercialize the CGM they were submitting fir clinical trials. I believe they will weather the storm with additional funding in excess of $3M.
Being it's traded on the otc I would not be surprised if it traded down to 30 to 35 cents after all the news is out. At those prices I would be a buyer not at 70 cents. That's my opinion.